Literature DB >> 10851351

Overexpression and localization of heat shock proteins mRNA in pancreatic carcinoma.

M Ogata1, Z Naito, S Tanaka, Y Moriyama, G Asano.   

Abstract

In the present study we examined the localization and overexpression of heat shock proteins (hsps), mainly hsp90, in pancreatic carcinoma tissue compared with control tissue (including chronic pancreatitis and normal pancreas tissue), with the aid of immunohistochemical staining, in situ hybridization and reverse transcriptase polymerase chain reaction. Hsp90 alpha mRNA was overexpressed more highly in pancreatic carcinoma than in the control tissue. The proliferating-cell-nuclear-antigen labeling index was also high in pancreatic carcinoma tissue compared with the other tissue. These findings suggest that the overexpression of hsp90 alpha mRNA in carcinomas may be correlated with cell proliferation. However, hsp90 beta was constitutively overexpressed almost equally in all groups of pancreatic tissue including pancreatic carcinoma, chronic pancreatitis and normal pancreas tissue. Immunohistochemical staining demonstrated a differentiation in the expression of hsp90 between histological types of pancreatic carcinoma. These findings suggest that hsp90 alpha is involved in carcinogenesis and that hsp90 beta is correlated to structural conformation. Hsp90 alpha and hsp90 beta seem to perform different functions in tissue containing malignant cells. P53, MDM2 and WAF1, that were cell-cycle-related oncogene product were more strongly expressed in the nuclei of the cancer cells of the cancer tissue. Especially, MDM2 was more strongly expressed in mucinous carcinoma and the mucin secreting tissues surrounding pancreatic carcinoma tissue. The expression of MDM2 protein might also be correlated to secretion systems during structural conformation and be correlated to hsp90 beta.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851351     DOI: 10.1272/jnms.67.177

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  21 in total

1.  Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo.

Authors:  Sayantani Sarkar; Devawati Dutta; Suman Kumar Samanta; Kaushik Bhattacharya; Bikas Chandra Pal; Jinping Li; Kaustubh Datta; Chhabinath Mandal; Chitra Mandal
Journal:  Int J Cancer       Date:  2012-07-09       Impact factor: 7.396

2.  Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Sasithorn Kaewkes; Porntip Laummaunwai; Somchai Pinlaor; Watchalin Loilome; Puangrat Yongvanit; Zhiliang Wu; Anucha Puapairoj; Vajarabhongsa Bhudhisawasdi
Journal:  Pathol Oncol Res       Date:  2011-07-13       Impact factor: 3.201

Review 3.  Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.

Authors:  Amanda J Walker; Sara R Alcorn; Amol K Narang; Katriana M Nugent; Aaron T Wild; Joseph M Herman; Phuoc T Tran
Journal:  Curr Probl Cancer       Date:  2013-10-05       Impact factor: 3.187

Review 4.  Immunotherapy in pancreatic cancer treatment: a new frontier.

Authors:  Komal Thind; Leslie J Padrnos; Ramesh K Ramanathan; Mitesh J Borad
Journal:  Therap Adv Gastroenterol       Date:  2016-10-17       Impact factor: 4.409

5.  Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells.

Authors:  R Jesnowski; Dmitri Zubakov; Ralf Faissner; Jörg Ringel; Jörg D Hoheisel; Ralf Lösel; Martina Schnölzer; Matthias Löhr
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

6.  Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells.

Authors:  Chun Hei Antonio Cheung; Huang-Hui Chen; Li-Ting Cheng; Kevin W Lyu; Jagat R Kanwar; Jang-Yang Chang
Journal:  Mol Cancer       Date:  2010-04-15       Impact factor: 27.401

7.  Withaferin A targets heat shock protein 90 in pancreatic cancer cells.

Authors:  Yanke Yu; Adel Hamza; Tao Zhang; Mancang Gu; Peng Zou; Bryan Newman; Yanyan Li; A A Leslie Gunatilaka; Chang-Guo Zhan; Duxin Sun
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

8.  Cytoplasmic HSP90α expression is associated with perineural invasion in pancreatic cancer.

Authors:  Hua Jiang; Bensong Duan; Chengzhi He; Shasha Geng; Xiaoying Shen; Hongmei Zhu; Haihui Sheng; Changqing Yang; Hengjun Gao
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

9.  ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.

Authors:  Jingxuan Yang; Zicheng Zhang; Yuqing Zhang; Xiaoling Ni; Guohua Zhang; Xiaobo Cui; Mingyang Liu; Can Xu; Qiang Zhang; Huiyun Zhu; Jie Yan; Vivian F Zhu; Yusheng Luo; John P Hagan; Zhaoshen Li; Jing Fang; Aminah Jatoi; Martin E Fernandez-Zapico; Lei Zheng; Barish H Edil; Michael S Bronze; Courtney W Houchen; Yi-Ping Li; Min Li
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 22.682

10.  Hsp90 Co-localizes with Rab-GDI-1 and regulates agonist-induced amylase release in AR42J cells.

Authors:  Robert Raffaniello; Daria Fedorova; Dawn Ip; Sarwish Rafiq
Journal:  Cell Physiol Biochem       Date:  2009-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.